Sex Hormone Binding Globulin (SHBG) plays a crucial role in regulating the bioavailability and activity of sex hormones in the body. SHBG binds tightly to testosterone, dihydrotestosterone (DHT), and estradiol, modulating their distribution and transport throughout the bloodstream.
This article provides a comprehensive overview of SHBG, covering its structure, production, function, laboratory testing methods, and clinical implications. Understanding SHBG is essential for comprehending the intricate interplay between hormones and their impact on various physiological processes, including reproduction, metabolism, and overall health.
We will also explore strategies to naturally support healthy SHBG levels, offering insights into dietary, lifestyle, and supplemental interventions that may help optimize hormonal balance and well-being.
Sex hormone binding globulin (SHBG) plays a crucial role in transporting the 17β-hydroxysteroid sex steroids testosterone and estradiol in plasma. SHBG also regulates hormone distribution between bound and free states.
Structurally, SHBG is a homodimeric glycoprotein with a single steroid-binding site, and it has a half-life of 7 days. It is primarily expressed in the liver, although it’s also produced in other tissues.
It is encoded by a single gene (Shbg), expressed in various tissues including the liver, testis, placenta, brain, and endometrium. SHBG that is produced in the testes is called androgen-binding protein. [4.]
Its plasma concentrations are regulated by factors such as the balance of androgens and estrogens, thyroid hormones, insulin, and dietary factors. [15.]
Many factors have been shown to affect SHBG levels:
Factors that Increase SHBG:
Factors that Decrease SHBG:
Throughout fetal development, plasma sex hormone-binding globulin (SHBG) production by the liver is crucial, particularly during late gestation when testosterone biosynthesis increases in male fetuses.
In humans, SHBG is present in fetal blood early in gestation and correlates with testosterone levels, suggesting a role in male sex differentiation. Maternal plasma SHBG levels surge during mid to late pregnancy, possibly to protect the fetus from maternal sex steroids.
During childhood and puberty, SHBG levels increase significantly and then decline progressively, influenced partly by thyroid hormone levels. Pubertal decreases in SHBG levels contribute to the maturation of the hypothalamo-pituitary-gonadal axis.
In adults, SHBG levels vary with nutritional status and metabolic health, being lower in conditions like obesity and polycystic ovarian syndrome (PCOS). Genetic factors, including polymorphisms in the SHBG gene, also influence SHBG levels.
During reproductive aging modest changes in SHBG levels occur, potentially related to metabolic or endocrine changes rather than declining sex hormone production.
SHBG serves as the primary carrier protein for sex hormones in serum, with approximately 70% of testosterone bound to SHBG with high affinity, 20-30% weakly bound to albumin, and 1-2% free.
Traditionally seen as a transporter of sex hormones to target tissues, recent studies suggest additional roles for SHBG. Evidence indicates its involvement in steroid hormone signal transduction at the plasma membrane and its uptake by cells, suggesting potential intracellular functions.
Studies have demonstrated SHBG internalization via the Megalin receptor in various cell types, with implications for androgen- or estrogen-mediated effects.
Furthermore, the discovery of a specific membrane receptor (SHBG-R) suggests a more intricate role for SHBG in modulating hormone effects at the cellular level, potentially inhibiting or amplifying androgen and estrogen effects through cAMP-mediated pathways.
Notably, in estrogen-dependent breast cancer, SHBG has been shown to inhibit estradiol-induced cell proliferation through SHBG-R, cAMP, and PKA signaling pathways, presenting a potential therapeutic strategy for managing estrogen-dependent tumors.
The free hormone hypothesis posits that only the unbound, or free, fraction of hormones in circulation is biologically active and able to exert physiological effects on target tissues, while hormone molecules bound to carrier proteins such as albumin or sex hormone-binding globulin (SHBG) remain inactive.
This hypothesis's validity varies depending on which step in tissue uptake, such as dissociation from plasma proteins or intracellular elimination, limits the hormone's net tissue uptake. [10.]
As a key binding protein for androgens and estrogens, SHBG plays a crucial role in regulating the bioactivity of these hormones according to the free hormone hypothesis.
SHBG restricts the entry of SHBG-bound testosterone (T) into target tissues, affecting its physiological functions in vivo. Contrary to the common belief that SHBG decreases free T concentrations, it appears that SHBG primarily increases total androgen and estrogen concentrations through hypothalamic-pituitary feedback and prolonged ligand half-life. [7.]
However, despite elevating total sex steroid levels, SHBG attenuates androgen bioactivity, leading to mild hypogonadal signs in reproductive organs without major phenotypic effects on other sexually dimorphic tissues.
Study findings support the clinical relevance of measuring free or bioavailable T and emphasize the need for careful interpretation of total sex steroid concentrations in the presence of SHBG. [7.]
In addition to its roles in maintaining levels of available sex hormones, SHBG has implications in cardiometabolic health and disease.
Abnormally low levels of plasma SHBG are reliable biomarkers for metabolic syndrome and its associated conditions, including obesity-related pathologies like polycystic ovarian syndrome (PCOS), type 2 diabetes, and cardiovascular disease.
The interplay between genetic variations in the human SHBG gene and metabolic disorders underscores the complex role SHBG plays in metabolic regulation and disease susceptibility.
SHBG's function extends beyond its classical role as a hormone transporter, with evidence suggesting involvement in gene expression regulation and tissue-specific interactions. In various species, including fish, SHBG exhibits specialized functions beyond steroid transport, suggesting evolutionary conservation of its diverse roles in reproductive physiology and environmental adaptation.
Blood testing for SHBG levels typically involves a blood draw.
Before undergoing SHBG testing, it's important to follow any specific preparation instructions provided by your healthcare provider, which may include fasting for a certain period to ensure accurate results.
Additionally, inform your healthcare provider about any medications or supplements you are taking, as certain drugs can affect SHBG levels and may need to be temporarily discontinued before testing. For example, it is typically recommended to avoid biotin supplementation for 72 hours prior to testing.
While it is important to consult with the ordering laboratory for their reference ranges, one company provides the following reference ranges: [1.]
Male:
20-49 years: 16.5−55.9 nmol/L
>49 years: 19.3−76.4 nmol/L
Female:
20-49 years: 24.6−122.0 nmol/L
>49 years: 17.3−125.0 nmol/L
Sex Hormone Binding Globulin levels increase in the presence of estrogen and thyroid hormones. Often, higher levels of SHBG are associated with positive health outcomes.
For example, elevated SHBG levels have been linked to a lower risk of type 2 diabetes and prostate cancer, although they are also linked to a higher risk of bone loss and fractures, hypogonadism in males, and hepatic cirrhosis. [2., 15.] It may also be caused by hyperthyroidism, as thyroid hormone stimulates SHBG production and release. [15.]
Increased levels may also be seen in pregnancy, ostensibly as a protective mechanism to shield the fetus from higher circulating hormone levels in the mother; in women using oral contraceptives, ostensibly because of estrogenic exposure; and in prepubertal children, thought to be due to higher thyroid hormone levels. [5., 11.]
Low SHBG levels have been linked to conditions such as polycystic ovary syndrome (PCOS), hirsutism, hair loss and infertility in women.
Low SHBG levels have been associated with an increased risk of developing type 2 diabetes, cardiovascular disease, and metabolic disorders including metabolic syndrome, as well as some cancers and arthritis in both genders. [18., 19.]
Click here to compare testing options and order testing for SHBG and other hormones.
[1.] 082016: Sex Hormone-binding Globulin | LabCorp. www.labcorp.com. https://www.labcorp.com/tests/082016/sex-hormone-binding-globulin
[2.] Arathimos R, Millard LAC, Bell JA, Relton CL, Suderman M. Impact of sex hormone-binding globulin on the human phenome. Hum Mol Genet. 2020 Jul 21;29(11):1824-1832. doi: 10.1093/hmg/ddz269. PMID: 32533189; PMCID: PMC7372548.
[3.] Fortunati, N. Sex Hormone-Binding Globulin: Not only a transport protein. What news is around the corner?. J Endocrinol Invest 22, 223–234 (1999). https://doi.org/10.1007/BF03343547
[4.] Hammond GL, Bocchinfuso WP. Sex hormone-binding globulin: gene organization and structure/function analyses. Horm Res. 1996;45(3-5):197-201. doi: 10.1159/000184787. PMID: 8964583.
[5.] Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod. 2011 Sep;85(3):431-41. doi: 10.1095/biolreprod.111.092593. Epub 2011 May 25. PMID: 21613632; PMCID: PMC4480437.
[6.] Kim JW, Kim DY. Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women. Metab Syndr Relat Disord. 2012 Dec;10(6):452-7. doi: 10.1089/met.2012.0036. Epub 2012 Sep 18. PMID: 22989086.
[7.] Laurent, M., Hammond, G., Blokland, M. et al. Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis. Sci Rep 6, 35539 (2016). https://doi.org/10.1038/srep35539
[8.] Le TN, Nestler JE, Strauss JF 3rd, Wickham EP 3rd. Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab. 2012 Jan;23(1):32-40. doi: 10.1016/j.tem.2011.09.005. Epub 2011 Nov 1. PMID: 22047952; PMCID: PMC3351377.
[9.] Li H, Pham T, McWhinney BC, Ungerer JP, Pretorius CJ, Richard DJ, Mortimer RH, d'Emden MC, Richard K. Sex Hormone Binding Globulin Modifies Testosterone Action and Metabolism in Prostate Cancer Cells. Int J Endocrinol. 2016;2016:6437585. doi: 10.1155/2016/6437585. Epub 2016 Nov 20. PMID: 27990161; PMCID: PMC5136390.
[10.] Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev. 1989 Aug;10(3):232-74. doi: 10.1210/edrv-10-3-232. PMID: 2673754.
[11.] Panzer C, Wise S, Fantini G, Kang D, Munarriz R, Guay A, Goldstein I. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. J Sex Med. 2006 Jan;3(1):104-13. doi: 10.1111/j.1743-6109.2005.00198.x. PMID: 16409223.
[12.] Reynolds AC, Dorrian J, Liu PY, et al. Impact of Five Nights of Sleep Restriction on Glucose Metabolism, Leptin and Testosterone in Young Adult Men. Mistlberger RE, ed. PLoS ONE. 2012;7(7):e41218. doi:https://doi.org/10.1371/journal.pone.0041218
[13.] Sáez-López C, Soriguer F, Hernandez C, Rojo-Martinez G, Rubio-Martín E, Simó R, Selva DM. Oleic acid increases hepatic sex hormone binding globulin production in men. Mol Nutr Food Res. 2014 Apr;58(4):760-7. doi: 10.1002/mnfr.201300304. Epub 2013 Oct 20. PMID: 24142580.
[14.] Shiels MS, Rohrmann S, Menke A, Selvin E, Crespo CJ, Rifai N, Dobs A, Feinleib M, Guallar E, Platz EA. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control. 2009 Aug;20(6):877-86. doi: 10.1007/s10552-009-9318-y. Epub 2009 Mar 10. PMID: 19277882; PMCID: PMC3004151.
[15.] Selby C. Sex hormone binding globulin: origin, function and clinical significance. Annals of clinical biochemistry. 1990;27 ( Pt 6):532-541. doi:https://doi.org/10.1177/000456329002700603
[16.] Steptoe, A., Kivimäki, M. Stress and cardiovascular disease. Nat Rev Cardiol 9, 360–370 (2012). https://doi.org/10.1038/nrcardio.2012.45
[17.] Wang A, Gerstein HC, Lee SF, Hess S, Paré G, Rydén L, Mellbin LG. Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial. Diab Vasc Dis Res. 2021 Mar-Apr;18(2):14791641211002475. doi: 10.1177/14791641211002475. PMID: 33752449; PMCID: PMC8481727.
[18.] Wang Y. Definition, Prevalence, and Risk Factors of Low Sex Hormone-Binding Globulin in US Adults. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3946-e3956. doi: 10.1210/clinem/dgab416. PMID: 34125885; PMCID: PMC8571812.
[19.] Weinberg ME, Manson JE, Buring JE, Cook NR, Seely EW, Ridker PM, Rexrode KM. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism. 2006 Nov;55(11):1473-80. doi: 10.1016/j.metabol.2006.06.017. Erratum in: Metabolism. 2007 Feb;56(2):296. PMID: 17046549; PMCID: PMC1633722.
[20.] Winters SJ, Gogineni J, Karegar M, et al. Sex Hormone-Binding Globulin Gene Expression and Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. 2014;99(12):E2780-E2788. doi:https://doi.org/10.1210/jc.2014-2640